Pharmacokinetic Study of AR882 in Subjects With Various Degrees of Renal Impairment
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Renal Impairment
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 75 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04646889
- Collaborators
- Iqvia Pty Ltd
- Investigators
- Study Director: Vijay Hingorani, MD, PhD, MBA Arthrosi Therapeutics
Get Well Soon